MedPath
NMPA Approval

Ceftizoxime Sodium for Injection

国药准字HJ20160452

October 13, 2021

H20160452

Drug Information

注射用头孢唑肟钠

注射剂

0.5g(按C₁₃H₁₃N₅O₅S₂计)

化学药品

October 13, 2021

October 12, 2026

Company Information

Applicant Company

8, Chungjeong-ro, Seodaemun-gu, Seoul 03742, Korea

Manufacturing Company

797-48, Manghyang-ro, Seonggeo-eup, Seobuk-gu, Cheonan-si, Chungcheongnam-do, Republic of Korea

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.